In other countries
The same active substances on other registers, the same brand first.
- WezlanaUnited States · 130MG/26ML, 45MG/0.5ML, 90MG/ML · injectable · Amgen INCSame brand
- WezlanaUnited States · 45MG/0.5ML · Injection · Amgen Inc.Same brand
- WezlanaUnited States · 45MG/0.5ML · Injection · Amgen Inc.Same brand
- Stelara®Serbia · 130mg/26mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Janssen-Cilag KFT BeogradSame form
- EpyztekBrazil · Samsung Bioepis br Pharmaceutical ltda.Same substance
- ImuldosaBrazil · Accord Farmacêutica LtdaSame substance
- OtulfiBrazil · Fresenius Kabi Brasil LtdaSame substance
- Imuldosa 130 MG Concentrado Para Solucion Para PerfusionSpain · 5 mg/ml · concentrado para solución para perfusión · Accord Healthcare S.L.U.Same substance
- Imuldosa 45 MG Solucion Inyectable en Jeringa PrecargadaSpain · 45 mg · solución inyectable en jeringa precargada · Accord Healthcare S.L.U.Same substance
- Imuldosa 90 MG Solucion Inyectable en Jeringa PrecargadaSpain · 90 mg/ml · solución inyectable en jeringa precargada · Accord Healthcare S.L.U.Same substance
- FymskinaEuropean Union · Formycon AGSame substance
- ImuldosaEuropean Union · Accord Healthcare S.L.U.Same substance
- OtulfiEuropean Union · Fresenius Kabi Deutschland GmbHSame substance
- ImuldosaCroatiaSame substance
- OtulfiCroatiaSame substance
- PyzchivaCroatiaSame substance
- FymskinaItaly · Soluzione iniettabile in siringa pre-riempita · Formycon AGSame substance
- ImuldosaItaly · Soluzione iniettabile in siringa pre-riempita · Accord Healthcare, S.L.U.Same substance
- OtulfiItaly · Soluzione iniettabile in siringa pre-riempita · Fresenius Kabi Deutschland GMBHSame substance
- Fymskina 130 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Formycon AGSame substance
- Fymskina 45 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Formycon AGSame substance
- Fymskina 90 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Formycon AGSame substance
- StelaraNew Zealand · Inj 90 mg per ml, 1 ml pre-filled syringeSame substance
- StelaraNew Zealand · Inj 130 mg vialSame substance
- StelaraNew Zealand · Inj 90 mg per ml, 1 ml prefilled syringeSame substance
- STELARA 130 mgRomania · 130mg · conc. pt. sol. perf. · JanssenSame substance
- STELARA 90 mgRomania · 90mg · sol inj. in seringa preumpluta · JanssenSame substance
- Stelara®Serbia · 45mg/0.5mL · rastvor za injekciju · PredstavniŠTvo Janssen-Cilag KFT BeogradSame substance
- Stelara®Serbia · 45mg/0.5mL · rastvor za injekciju · PredstavniŠTvo Janssen-Cilag KFT BeogradSame substance
- STELARA 130MG/26ML Concentrate for solution for infusionSaudi Arabia · Janssen-CilagSame substance
- Stelara 45MG/0.5ML Solution for InjectionSaudi Arabia · Baxter Pharmaceutical Solution LLCSame substance
- STELARA 90mg/1ml SOLUTION FOR INJECTIONSaudi Arabia · Baxter Pharmaceutical Solution LLCSame substance
- Ichalig Solution for Injection in Pre-Filled Syringe 45mg/0.5mlSingapore · 45mg/0.5ml · injection, solution · Sindor Healthcare Pte. LTD.Same substance
- Stelara Solution for Injection in Pre-Filled Syringe 45 mg/0.5mLSingapore · 45mg/0.5mL · injection, solution · Johnson & Johnson International (Singapore) Pte LTDSame substance
- Steqeyma® Solution for Injection in Pre-Filled Syringe 45MG/0.5MLSingapore · 45 mg/0.5ml · injection, solution · Celltrion Healthcare Singapore Private LimitedSame substance
- STELARA Concentrate for Solution for Infusion (130 mg/26mL)Taiwan · 注射液劑 · 嬌生股份有限公司Same substance
- Stelara Solution for InjectionTaiwan · 預充填式注射劑 · 嬌生股份有限公司Same substance
- Stelara Solution for InjectionTaiwan · 預充填式注射劑 · 嬌生股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ustekinumab
- Strength
- 45 MG / 0.5 ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 1 Mar 2024
- Registration
- DIN 02544180
- Marketing authorisation holder
- Amgen Canada INC
- ATC code
- L04AC05
- Supply
- PRESCRIPTION, SCHEDULE D